Testing effectiveness (Phase 2)Study completedNCT00675857
What this trial is testing
A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
Who this might be right for
Diabetes Mellitus, Type 2Metabolic Syndrome X
Bellus Health Inc. - a GSK company 200